Extracellular Microvesicles Modified with Arginine-Rich Peptides for Active Macropinocytosis Induction and Delivery

Kenta Morimoto1, Jojiro Ishitobi1, Kosuke Noguchi1

  • 1Department of Biological Chemistry, Graduate School of Science, Osaka Metropolitan University, 1-1, Gakuen-cho, Naka-ku, Sakai 599-8531, Osaka, Japan.

Insights

Cellular uptake of microvesicles (MVs) is enhanced by macropinocytosis, a process involving cell membrane engulfment. This study modified MVs with peptides to improve intracellular delivery via macropinocytosis.

Area of Science:

  • Cell Biology
  • Biotechnology
  • Nanomedicine

Background:

  • Extracellular vesicles (EVs), including exosomes and microvesicles (MVs), are crucial for intercellular communication by transferring bioactive molecules.
  • The precise mechanisms of cellular uptake for different EV subpopulations, especially larger MVs, are not fully understood.
  • Receptor-mediated endocytosis is inefficient for cellular uptake of MVs due to their size.

Purpose of the Study:

  • To investigate and enhance the cellular uptake mechanisms of microvesicles (MVs).
  • To explore the role of macropinocytosis in MV cellular internalization.
  • To develop strategies for efficient intracellular delivery of therapeutic molecules using MVs.

Main Methods:

  • Induction of macropinocytosis through experimental techniques.
  • Modification of MV membranes with arginine-rich cell-penetrating peptides.
  • Assessment of MV uptake enhancement via macropinocytosis.

Main Results:

  • Macropinocytosis significantly enhances the cellular uptake of microvesicles (MVs).
  • Modified MVs demonstrated improved internalization through macropinocytosis-mediated pathways.
  • The study provides a novel method for enhancing intracellular delivery of therapeutic payloads.

Conclusions:

  • Macropinocytosis is a key mechanism for cellular uptake of MVs.
  • Peptide modification of MVs can effectively leverage macropinocytosis for enhanced intracellular delivery.
  • This approach holds potential for developing advanced drug delivery systems.

Related Concept Videos

Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.5K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
104.4K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.1K